領航醫藥生物科技：中期報告2021-2022.pdf

1、(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)(於開曼群島註冊成立並於百慕達存續之有限公司)(Stock Code 股份代號：399)2021/22中期報告Interim ReportCMYCMMYCYCMYKai1640322128116_InnovativePharmBio IR2021-22 Cover_output.pdf 1 24/12/2021 下午1:02Contents目錄2Corporate Information公司資料4Chairmans Statem

2、ent主席報告6Management Discussion and Analysis管理層討論及分析15Other Information Provided in Accordance with the Listing Rules根據上市規則披露之其他資料21Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income簡明綜合損益及其他全面收益表24Condensed Consolidated Statement of Financial Position簡明綜合財務狀況表27Condense

3、d Consolidated Statement of Changes in Equity簡明綜合權益變動表29Condensed Consolidated Statement of Cash Flows簡明綜合現金流量表30Notes to the Condensed Consolidated Financial Statements簡明綜合財務報表附註Corporate Information公司資料2INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED 2021/22 Interim ReportBOARD OF DIRECTORSExecutive Dir

4、ectorsGao Yuan XingTang RongNon-executive DirectorsJiang Nian(Chairman)Xiao YanWu YanminIndependent non-executive DirectorsChen WeijunWang RongliangChen JinzhongAudit CommitteeChen Weijun(Chairman)Wang RongliangChen JinzhongRemuneration CommitteeWang Rongliang(Chairman)Jiang NianChen JinzhongNominat

5、ion CommitteeJiang Nian(Chairman)Wang RongliangChen JinzhongHONORARY CHAIRMANMao YuminCOMPANY SECRETARYPoon Hon YinREGISTERED OFFICEClarendon House2 Church StreetHamilton HM 11,Bermuda董事會執行董事高源興唐榕非執行董事蔣年（主席）肖焱鄔燕敏獨立非執行董事陳偉君王榮樑陳金中審核委員會陳偉君（主席）王榮樑陳金中薪酬委員會王榮樑（主席）蔣年陳金中提名委員會蔣年（主席）王榮樑陳金中名譽主席毛裕民公司秘書潘漢彥註冊辦事處C

6、larendon House2 Church StreetHamilton HM 11,BermudaCorporate Information公司資料32021/22年中期報告 領航醫藥及生物科技有限公司PRINCIPAL PLACE OF BUSINESS IN HONG KONGUnit No.2111,21/F.West Tower Shun Tak Centre168200 Connaught Road CentralSheung Wan,Hong KongPRINCIPAL SHARE REGISTRAR AND TRANSFER AGENTConyers Corporate Se